Today: 7 February 2026
Subscribe

authID (AUID) Soars After Joining NVIDIA Connect: How Today’s AI Security Deal Could Reshape Its Future

authID (AUID) Soars After Joining NVIDIA Connect: How Today’s AI Security Deal Could Reshape Its Future

Denver-based biometric identity specialist authID Inc. (NASDAQ: AUID) is back on traders’ radar today after announcing it has joined the NVIDIA Connect Program, a move that sent the small-cap stock sharply higher and spotlighted its ambitious push into AI agent security and governance. GlobeNewswire+1 NVIDIA Connect: A Strategic Door Into the AI Big Leagues This morning, authID revealed that it has been accepted into NVIDIA Connect, a global ecosystem that gives AI-focused companies access to NVIDIA’s GPU technologies, AI and machine learning frameworks, training, and collaboration opportunities. GlobeNewswire+1 In its GlobeNewswire release, authID framed the step as a “key milestone”
20 November 2025
·
Bonk, Inc. (BNKK) Stock Jumps on Q3 2025 Earnings: Debt-Free Balance Sheet and 1,200% Beverage Revenue Surge

Bonk, Inc. (BNKK) Stock Jumps on Q3 2025 Earnings: Debt-Free Balance Sheet and 1,200% Beverage Revenue Surge

Bonk, Inc. (NASDAQ: BNKK) is back in the spotlight today after the company reported third-quarter 2025 results that complete its balance sheet cleanup, deliver triple‑digit revenue growth, and mark the first-ever gross profit for its beverage segment. Investors responded quickly: BNKK traded sharply higher in Thursday’s session as traders digested the numbers and the company’s evolving hybrid strategy spanning functional beverages and digital assets. GlobeNewswire+1 Key Takeaways for BNKK on 20 November 2025 Q3 2025: Debt Wiped, Cash Built In a GlobeNewswire release this morning, Bonk, Inc. called the September quarter a “definitive turning point” in its transformation from its
20 November 2025
·
Founder Group Limited (FGL) on 20 November 2025: Nasdaq Warning, Surging Penny Stock, and a RM1.16 Billion Solar Megaproject

Founder Group Limited (FGL) on 20 November 2025: Nasdaq Warning, Surging Penny Stock, and a RM1.16 Billion Solar Megaproject

Founder Group Limited (NASDAQ: FGL) has become one of the most talked‑about micro‑cap solar stocks in November, as traders pile into the name on the back of a Nasdaq minimum bid‑price warning and a string of ambitious renewable‑energy announcements in Malaysia. As of 20 November 2025, the company sits at a crossroads: it is fighting to keep its Nasdaq listing while simultaneously positioning itself at the center of a multi‑billion‑ringgit solar and green data‑center build‑out. GlobeNewswire+2 FGL stock today: volatile penny name on traders’ radar On 20 November 2025, Founder Group shares are trading around $0.40–$0.42, up strongly from yesterday’s
20 November 2025
·
Inspire Veterinary Partners (IVP) Plunges Over 60%, Then Rebounds as Nasdaq Delisting Deadline Hits Today

Inspire Veterinary Partners (IVP) Plunges Over 60%, Then Rebounds as Nasdaq Delisting Deadline Hits Today

On Thursday, November 20, 2025, Inspire Veterinary Partners, Inc. (Nasdaq: IVP) sits at the center of one of the most volatile micro‑cap stories on the market, with its stock whipsawing after a Nasdaq delisting notice and a critical appeal deadline that falls today. SEC+2SEC+2 After collapsing more than 58–62% on Wednesday to near its 52‑week low following news of the delisting threat, IVP has bounced sharply in Thursday’s pre‑market and intraday trading — but remains a tiny, highly speculative name fighting to keep its Nasdaq listing. Benzinga+3AInvest+3FinancialContent+3 IVP Stock Today: Violent Rebound After a Brutal Sell‑Off By early afternoon on
20 November 2025
Jacobs Solutions (J) Beats Q4 2025 Estimates, Targets 16% EPS Growth for 2026 on Record Backlog

Jacobs Solutions (J) Beats Q4 2025 Estimates, Targets 16% EPS Growth for 2026 on Record Backlog

Jacobs Solutions Inc. (NYSE: J) kicked off Thursday’s trading session with a flurry of news: stronger‑than‑expected fiscal fourth‑quarter 2025 results, a bullish 2026 earnings outlook, fresh SEC filings, and continued shareholder returns via dividends and buybacks. The engineering and professional services company reported solid top‑line growth, expanding margins on an adjusted basis and a record backlog, even as GAAP profit declined year over year due mainly to prior‑period investment gains. Jacobs+1 Q4 2025: Revenue Grows 6.6%, Adjusted EPS Jumps 28% Jacobs’ fiscal fourth quarter ended September 26, 2025, and the company’s headline numbers came in ahead of Wall Street expectations:
20 November 2025
··
Freight Technologies (FRGT) Seals Fetch AI Deal and $1M Financing as Zayren Launch Supercharges Volatile Rally

Freight Technologies (FRGT) Seals Fetch AI Deal and $1M Financing as Zayren Launch Supercharges Volatile Rally

Freight Technologies, Inc. (NASDAQ: FRGT), the AI‑driven logistics platform known as Fr8Tech, is doubling down on its artificial intelligence strategy and reshaping its balance sheet after a dramatic stock surge. On Thursday, the company announced a multi‑year AI services agreement with Fetch Compute (Fetch AI), detailed a new $1 million senior convertible note financing, and unwound a prior $5.2 million FET token deal – all just one day after the commercial launch of its new AI pricing and carrier‑matching platform, Zayren. GlobeNewswire+2SEC+2 The moves cap a whirlwind 48 hours that have sent FRGT shares swinging wildly, with intraday gains of
20 November 2025
··
GE Vernova (GEV) Rallies Again on Taiwan Wind Deal and B20 Grid Breakthrough – Key Updates for 20 November 2025

GE Vernova (GEV) Rallies Again on Taiwan Wind Deal and B20 Grid Breakthrough – Key Updates for 20 November 2025

GE Vernova Inc. (NYSE: GEV) extended its November rally on Thursday as investors digested a landmark wind repower contract in Taiwan, fresh global grid milestones announced at B20 South Africa, and a wave of institutional positioning in the stock. GE Vernova stock today: rally extends after Taiwan deal GE Vernova shares continued higher on Thursday, 20 November 2025, building on Wednesday’s sharp move following the company’s first onshore wind repower upgrade contract outside the United States. According to daily price data from Investing.com, GE Vernova traded in a range of roughly $602–$616 on Thursday, with the most recent reading around
20 November 2025
·
NetEase (NTES) Q3 2025 Earnings Today: Revenue Miss, $5B Buyback Extension and Blizzard Pipeline Move the Stock

NetEase (NTES) Q3 2025 Earnings Today: Revenue Miss, $5B Buyback Extension and Blizzard Pipeline Move the Stock

NetEase Inc. (NASDAQ: NTES) reported Q3 2025 net revenue of RMB 28.4 billion (+8.2% YoY) but missed Wall Street estimates, even as gaming growth, a $5 billion share repurchase extension, a fresh dividend and Blizzard titles like Diablo IV shape the company’s outlook. Snapshot: What Happened With NetEase Today Chinese internet and gaming giant NetEase, Inc. (NASDAQ: NTES; HKEX: 9999) reported its Q3 2025 unaudited financial results before the market opened on November 20, 2025. Revenue grew, profit rose, and cash piled up, but top-line and bottom-line numbers came in below analyst expectations, prompting an early sell-off before shares later
20 November 2025
···
Applied Digital (APLD) Soars on Nov. 20 as Babcock & Wilcox Power Deal, $2.35B Notes Offering and AI “Factory” Buildout Collide

Applied Digital (APLD) Soars on Nov. 20 as Babcock & Wilcox Power Deal, $2.35B Notes Offering and AI “Factory” Buildout Collide

Applied Digital Corporation (NASDAQ: APLD) is back in the spotlight on 20 November 2025, with its stock jumping again as traders digest a wave of news around the company’s ambitious AI data‑center “Factory” strategy, massive new debt financing, and a long‑term power partnership with Babcock & Wilcox (B&W). As of early afternoon trading on Thursday, APLD shares are around $25–26, up roughly 10% on the day versus Wednesday’s close near $23.09, according to real‑time quote data. StockAnalysis The move extends a volatile week in which the AI data‑center specialist has whipsawed on financing headlines but still remains up well over
20 November 2025
·
Micron Stock Today (MU): UBS Lifts Price Target to $275 as AI Memory Boom Collides With Capex Fears – November 20, 2025

Micron Stock Today (MU): UBS Lifts Price Target to $275 as AI Memory Boom Collides With Capex Fears – November 20, 2025

Micron Technology (NASDAQ: MU) is back in the spotlight on Thursday, November 20, 2025, after UBS sharply raised its price target to $275 on the back of an “unusually tight” memory market and booming AI demand — even as investors continue to fret about higher capital spending flagged at a major tech conference this week. Investing As of mid‑afternoon trading, Micron shares are hovering around $220, down roughly 2.5% on the day, but still massively higher year to date after a triple‑digit rally driven by AI data‑center demand and leadership in high‑bandwidth memory (HBM). Barchart Key Takeaways for November 20,
20 November 2025
····
Cerence (CRNC) Stock Soars After Q4 2025 Earnings Beat and Bold FY26 AI Guidance – November 20, 2025

Cerence (CRNC) Stock Soars After Q4 2025 Earnings Beat and Bold FY26 AI Guidance – November 20, 2025

Cerence Inc. (NASDAQ: CRNC), the automotive voice and AI specialist, is back in the spotlight today after a powerful earnings-driven rally. Following its fiscal Q4 and full-year 2025 report released after the bell on November 19, Cerence stock is surging as investors digest a clean revenue beat, sharply improved cash generation and an ambitious outlook for fiscal 2026 built around generative AI, its xUI cockpit platform and a major patent license deal. Cerence Inc.+2Stock Titan+2 As of early afternoon trading on Thursday, November 20, CRNC is changing hands around $10.95, up about 38% from Wednesday’s close of approximately $7.92, according
20 November 2025
·
InMed Pharmaceuticals (INM) Soars on Alzheimer’s Breakthrough: INM‑901 Study Sparks 20%+ Stock Rally on November 20, 2025

InMed Pharmaceuticals (INM) Soars on Alzheimer’s Breakthrough: INM‑901 Study Sparks 20%+ Stock Rally on November 20, 2025

InMed Pharmaceuticals Inc. (NASDAQ: INM) is back in the spotlight today after a sharp bounce in its share price, driven by fresh preclinical data for its Alzheimer’s disease candidate INM‑901 and heavy speculative trading in the micro‑cap biotech name. On Wednesday, INM shares closed at $1.23, down almost 16% on the day, before surging about 22% after hours to around $1.50.Benzinga That momentum rolled into Thursday’s pre‑market session, where multiple market data sources showed gains of roughly 20–26%, with INM changing hands in the $1.49–$1.55 range on unusually high volume.Benzinga+2RTTNews+2 As regular trading gets underway, real‑time quote providers still show
20 November 2025
··
Nuvation Bio (NUVB) Rockets to 3‑Year High as Wall Street Lifts Price Targets on IBTROZI Momentum – November 20, 2025

Nuvation Bio (NUVB) Rockets to 3‑Year High as Wall Street Lifts Price Targets on IBTROZI Momentum – November 20, 2025

Nuvation Bio Inc. has become one of the hottest tickers in biotech this week. On November 20, 2025, NUVB is trading near a three‑year high after a powerful earnings beat, accelerating uptake of its lung‑cancer drug IBTROZI™ (taletrectinib), and a wave of bullish analyst upgrades that continue to roll in today. Seeking Alpha+2Trefis+2 At the time of writing, Nuvation Bio shares trade around $7.15, up roughly 49% today, with an intraday high of $7.21 and heavy trading volume, extending a massive multi‑day rally. Quiver Quantitative Key Takeaways for November 20, 2025 NUVB Stock: From Under‑the‑Radar Biotech to Market Standout The
20 November 2025
PACS Group (PACS) Stock Soars as Q3 2025 Earnings, Restatement Cleanup and Bullish Guidance Ignite Rally

PACS Group (PACS) Stock Soars as Q3 2025 Earnings, Restatement Cleanup and Bullish Guidance Ignite Rally

PACS Group, Inc. (NYSE:PACS) is back in the spotlight on Thursday after delivering strong third‑quarter 2025 results, completing a high‑stakes financial restatement process and unveiling upbeat guidance that has sent the stock to fresh 52‑week highs. PACS Group, Inc.+2Stocktwits+2 The post‑acute care operator’s shares have surged this week as investors digest a rare combination of record revenue growth, restored SEC compliance and a series of bullish analyst calls from RBC Capital and Truist Securities. Investing.com+2 As of early afternoon on November 20, PACS stock is trading around $16.83, up sharply over the past week and near its 52‑week high of
20 November 2025
·
Moderna (MRNA) Sets 3‑Year mRNA Growth Plan After $1.5 Billion Loan and $140 Million U.S. Expansion – November 20, 2025

Moderna (MRNA) Sets 3‑Year mRNA Growth Plan After $1.5 Billion Loan and $140 Million U.S. Expansion – November 20, 2025

Moderna (MRNA) secured a $1.5 billion Ares loan, outlined a three‑year strategy targeting up to 10% revenue growth in 2026, and confirmed a $140 million U.S. manufacturing expansion as it races toward cash breakeven by 2028. Moderna’s pivotal day: liquidity boost, strategy reset and manufacturing push Moderna, Inc., the mRNA‑vaccine pioneer behind Spikevax®, is back in the spotlight today after unveiling a trio of significant updates on November 20, 2025: The moves come as Moderna tries to navigate a steep post‑pandemic revenue reset, heavy R&D spending and investor skepticism about how quickly its broad mRNA pipeline can translate into sustainable
20 November 2025
··
Stock Market Today, Nov. 20, 2025: Nvidia Rally vs Fed Caution on FOMC Minutes, Trade Gap and Oil

WeShop (WSHP) Stock Today, 20 November 2025: U.S. App Launch, 500% Rally and Sharp Pre‑Market Selloff

WeShop Holdings Limited (NASDAQ: WSHP) is back in the spotlight today, 20 November 2025, as its first U.S. social‑commerce app goes live, the company prepares to ring the Nasdaq Closing Bell in Times Square, and its newly listed shares swing violently after a spectacular 506% surge yesterday. Quiver Quantitative+2 Key points for 20 November 2025 WSHP’s wild first week: from quiet debut to meme‑style rocket Direct listing and first trades WeShop listed on the Nasdaq Capital Market via direct listing on 14 November 2025, with Class A ordinary shares trading under the ticker WSHP. On day one, the stock: FinancialContent+1
20 November 2025
·
Stock Market Today, Nov. 20, 2025: Nvidia Rally vs Fed Caution on FOMC Minutes, Trade Gap and Oil

Stock Market Today, Nov. 20, 2025: Nvidia Rally vs Fed Caution on FOMC Minutes, Trade Gap and Oil

Nvidia’s blockbuster earnings have lit a fire under U.S. stock futures this Thursday, but a hawkish set of Federal Reserve minutes, a sharply narrower U.S. trade deficit and fresh crude oil inventory data are all reminding investors that the macro backdrop is anything but simple. Futures point to a strong open for the Dow, S&P 500 and Nasdaq, even as markets dial back expectations for a December Fed rate cut and digest delayed economic data following the 43‑day government shutdown. Reuters+4TipRanks+424/7 Wall St.+4 Key takeaways for November 20, 2025 Nvidia earnings rekindle the AI trade and power stock futures After
20 November 2025
····
Psyence BioMed (NASDAQ: PBM) Jumps as It Secures Pharmaceutical‑Grade Ibogaine Supply for Global Clinical Trials – 20 November 2025

Psyence BioMed (NASDAQ: PBM) Jumps as It Secures Pharmaceutical‑Grade Ibogaine Supply for Global Clinical Trials – 20 November 2025

Psyence Biomedical Ltd. (NASDAQ: PBM) (“Psyence BioMed”) is back in the spotlight today after announcing a “major breakthrough” in its ibogaine supply chain and emerging as one of the more active healthcare micro‑caps in pre‑market trading. The Nasdaq‑listed psychedelic biotech disclosed that it has secured a sustainable, pharmaceutical‑grade ibogaine supply through its strategic partner PsyLabs, including an initial shipment of 50 kg of high‑potency iboga bark that is now being processed into ibogaine HCl and full‑spectrum Total Alkaloid Extracts for global clinical and therapeutic markets. GlobeNewswire+1 At the same time, Psyence BioMed’s stock was flagged by Benzinga among Thursday’s top
20 November 2025
··
Bath & Body Works (BBWI) Stock Hit by Q3 2025 Miss, Holiday Sales Warning and New ‘Consumer First’ Turnaround Plan

Bath & Body Works (BBWI) Stock Hit by Q3 2025 Miss, Holiday Sales Warning and New ‘Consumer First’ Turnaround Plan

Bath & Body Works, Inc. (NYSE: BBWI) shares swung wildly on Thursday after the specialty retailer reported softer-than-expected third-quarter 2025 results, slashed its full‑year outlook and warned of weaker holiday demand, even as it unveiled an ambitious new transformation strategy dubbed the “Consumer First Formula.” Finviz+3Reuters+3 As of early afternoon trading, BBWI was changing hands around $21.04 per share, after tumbling as much as mid‑teens percent in pre‑market and early trading. The stock is still down roughly 46% year to date and about 31% over the past 12 months, putting it near multi‑year lows despite a modest intraday rebound. Times
20 November 2025
·
Block, Inc. (XYZ) Stock Jumps on $5 Billion Buyback and Bold 2028 Profit Targets – 20 November 2025

Block, Inc. (XYZ) Stock Jumps on $5 Billion Buyback and Bold 2028 Profit Targets – 20 November 2025

Block, Inc. (NYSE: XYZ) — the Jack Dorsey‑led fintech behind Cash App and Square — is back in the spotlight today after unveiling an ambitious three‑year growth roadmap and a fresh $5 billion share repurchase authorization. The new plan, presented at the company’s 2025 Investor Day, has sent the stock up roughly 7–9% as investors reassess the beaten‑down fintech name. Insider Monkey+3BeInCrypto+3Investors+3 The strategy leans heavily on Block’s two core ecosystems, Cash App and Square, while doubling down on Bitcoin payments, stablecoins and AI‑driven credit and analytics tools. investors.block.xyz+2Digital Transactions+2 Key takeaways for Block, Inc. (XYZ) on 20 November 2025
20 November 2025
1 … 1,270 1,271 1,272 1,273 1,274 … 1,632

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop